Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs. - Wikidata - wikimedia - TriplyDB

Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.

Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.

http://www.wikidata.org/entity/Q37464651

about

The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancer Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.Altered peroxisome-proliferator activated receptors expression in human endometrial cancer.Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)Establishing the Role of PPARβ/δ in Carcinogenesis Vascular effects of prostacyclin: does activation of PPARδ play a role?Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.Targeting peroxisome proliferator-activated receptor-β/δ in colon cancer: how to aim?Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis Roles of PPAR transcription factors in the energetic metabolic switch occurring during adult neurogenesis.Trans fatty acids affect cellular viability of human intestinal Caco-2 cells and activate peroxisome proliferator-activated receptors.Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention.Erratum to “Peroxisome Proliferator-Activated Receptors Alpha, Beta, and Gamma mRNA and Protein Expression in Human Fetal Tissues”

P2860

Q24601222-5834EEE0-9DD9-4BFD-B15D-34931212BEC4 Q33625872-C2687C6C-A6A7-4356-B8B4-06F643F06769 Q34128015-CB5493C8-CCC9-4C9C-B35F-D2C47DC4CAEC Q34332222-1CA0421F-9240-47C2-8BB3-1178D4674B54 Q34625038-64312E56-2FC3-4FE2-96EE-7D5AAC924D11 Q34680466-FFA43629-3232-476D-9560-76E9523CAF50 Q35613331-7AFFF1D3-0AD8-4E53-9C94-2D02BEDB1E8E Q35789097-518E1A93-281E-4EE1-9F55-7F715640CF78 Q35961671-AB592195-43B6-461A-8322-7C733666052C Q36244704-C6D06EFA-954A-4205-80BD-9E40A124F222 Q36287741-8A49F810-75F3-4B33-8857-504F74BCAC78 Q36352434-E7B6D47C-65A2-4668-B3D7-BF76A43585A5 Q36582381-F46B6CFE-9457-46E5-96BA-9E637C76F72D Q37388607-056A52AD-5BB9-43BE-B5A0-DF62FB7BDBB5 Q37478082-E2BC4D87-9B7E-4C03-80FF-74D1F7B37272 Q38730462-86A14F5B-4C54-44B3-A8EE-C62C455EE7D1 Q39201595-2CA69422-200E-408C-9025-04EB4BC6D461 Q41694098-39812845-4AC9-447C-9F59-96D696397DB9 Q42551493-8AAF909A-8C00-46E7-BDA3-31F9D744A94A Q58653505-587BD662-7330-4FBA-B5F5-D7B14BA1FD9E

P2860

Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.

http://www.wikidata.org/entity/Q37464651

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Regulation of peroxisome proli ...... roidal antiinflammatory drugs.

@en

Regulation of peroxisome proli ...... roidal antiinflammatory drugs.

@nl

type

label

Regulation of peroxisome proli ...... roidal antiinflammatory drugs.

@en

Regulation of peroxisome proli ...... roidal antiinflammatory drugs.

@nl

prefLabel

Regulation of peroxisome proli ...... roidal antiinflammatory drugs.

@en

Regulation of peroxisome proli ...... roidal antiinflammatory drugs.

@nl

P1433

Q37464651-763A6198-675E-45F5-8E8A-EDF3096404ED

P1476

Q37464651-A54C0AFB-BB0F-433C-9762-B91D0BBB5F49

P2093

Q37464651-07C05AA9-FC95-4F0B-B7CD-A97E1B9CC867

Q37464651-189E4B51-DF30-4016-ADB8-2CF078485DB3

Q37464651-3A3936EC-BD13-47A1-9F5B-92253A3FA083

Q37464651-777CDF90-C9B2-4799-B73A-69532BDB3B0F

Q37464651-A4F16345-C5DB-41F0-8B96-C9549CE47419

Q37464651-BC3FE34E-AB22-463B-B4E4-473CD6BC2F67

Q37464651-D401021D-83FB-4116-89E4-F5939E4966DF

P2860

Q37464651-02AD25AF-359A-4FFA-8DE9-4EE5F8B5581B

Q37464651-2252A62D-81F1-4BA0-A76C-BDD075DFCE11

Q37464651-258AABC3-7E67-4E62-BDF5-B20AB7CA8597

Q37464651-33BD2EDE-4996-4877-A8B1-5FA8F942900E

Q37464651-3A6EABED-7EE1-4AB2-A970-87A92F30FA49

Q37464651-3D2F902D-9842-41B0-83D6-E533B874CF58

Q37464651-443B3262-798A-4DB3-9871-CB844E460F83

Q37464651-4A13179C-ED0F-4CC7-B3FC-CD653F9130CA

Q37464651-4BBB9E33-3A37-4406-9121-173591271F6B

Q37464651-514266BA-8447-4730-926A-CE3A9FFDAF87

P304

Q37464651-71BB119C-BF57-406C-BBE1-F7750C6C6BE5

P31

Q37464651-D5B1F85F-3C4A-427B-ABD0-8A35D943CC9A

P356

Q37464651-B9EF3C3B-7CA2-4AD9-8B13-18E52D6C55E0

P433

Q37464651-C05EC663-B1F1-4A6B-BC49-023944226C25

P478

Q37464651-1F5F4873-4C28-4CD3-B410-BDCFA1C0224F

P50

Q37464651-463F2496-86FB-495E-97E0-E24CA0C467D8

P577

Q37464651-9625EEAF-4FAB-44D2-A528-CAE5867429C2

P5875

Q37464651-ECC541EC-870A-4480-BB6D-4D541121E310

P698

Q37464651-DBAEDCC7-7E94-4516-BB74-060927E03EC8

P932

Q37464651-1FFD52CF-BD02-44C7-AFFA-17C1CAF43277

P356

P1433

Molecular Carcinogenesis

P1476

Regulation of peroxisome proli ...... eroidal antiinflammatory drugs

@en

P2093

Basil Rigas

http://www.w3.org/2001/XMLSchema#string

Frank J Gonzalez

http://www.w3.org/2001/XMLSchema#string

Jennie L Williams

http://www.w3.org/2001/XMLSchema#string

Jennifer E Foreman

http://www.w3.org/2001/XMLSchema#string

Joseph M Sorg

http://www.w3.org/2001/XMLSchema#string

Kathleen S McGinnis

http://www.w3.org/2001/XMLSchema#string

Margie L Clapper

http://www.w3.org/2001/XMLSchema#string

P2860

The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells

PPARdelta regulates glucose metabolism and insulin sensitivity

AMPK and PPARdelta agonists are exercise mimetics

Expression of PPARdelta in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology

Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice

NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice

NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis

The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

Differential regulation and properties of angiopoietin-like proteins 3 and 4

P304

942-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MC.20546

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24401951

http://www.w3.org/2001/XMLSchema#string

P698

19415698

http://www.w3.org/2001/XMLSchema#string

P932

2790141

http://www.w3.org/2001/XMLSchema#string